Cite

HARVARD Citation

    Lioudaki, E. et al. (2017). Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential Risks. Clinical pharmacology & therapeutics. 102 (3), pp. 470-480. [Online]. 
  
Back to record